Imara

Cancer drug biotech Enliven shifts to reverse to move forward as a public company
MedCity News
Sun, 10/16/22 - 05:13 pm
Enliven Therapeutics
Imara
cancer
chronic myeloid leukemia
After safety setbacks, job cuts, Imara sells its top drug to a startup
BioPharma Dive
Thu, 09/8/22 - 04:38 pm
Imara
layoffs
tovinontrine
Imara to reduce staff by 83% amid biotech shakeout
BioPharma Dive
Mon, 04/18/22 - 10:50 am
Imara
layoffs
tovinontrine
beta thalassemia
sickle cell disease
Imara’s two trial flops in blood disorders dim drug’s prospects in heart failure
MedCity News
Wed, 04/6/22 - 12:21 pm
Imara
clinical trials
blood disorders
tovinontrine
sickle cell disease
beta thalassemia
Imara attempts to spin weak data into an 'encouraging' result — but investors aren't having it
Endpoints
Wed, 01/6/21 - 11:07 pm
Imara
IMR-687
sickle cell disease
As coronavirus spreads, a biotech IPO squeaks through. Others may 'wait and see'
BioPharma Dive
Fri, 03/13/20 - 12:51 pm
IPOs
coronaviruses
Imara
COVID-19
A biotech tests Wall Street's roiled waters and comes away with a $75M IPO haul
Endpoints
Thu, 03/12/20 - 10:46 am
Imara
IPOs
Blood disorder startup files for $86M IPO
Bizjournals
Wed, 02/19/20 - 09:52 am
IPOs
Imara
sickle cell disease
beta thalassemia
Pfizer-backed biopharma company Imara files for IPO
Marketwatch
Sat, 02/15/20 - 02:23 pm
Pfizer
Imara
IPOs
hemoglobinopathies